Multiple myeloma current treatment algorithms | Blood Cancer Journal
CLINICAL TRIAL FACT SHEET
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma | Future Oncology
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials | Scientific Reports
SYNOPSIS
DVd Weekly Daratumumab-Bortezomib-Dexamethasone weekly Cycles 9 onwards
Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma - eBioMedicine
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
NCCN guidelines version l. 2013 multiple myeloma | Download Table
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US | SpringerLink
Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study | BMJ Open
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study - The Lancet Oncology
DVd-T SC Bortezomib-Daratumumab-Dexamethasone-Thalidomide v1
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
Multiple Myeloma - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
Current Oncology | Free Full-Text | Management of Multiple Myeloma: A Review for General Practitioners in Oncology
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Approved for use in:
